Instil Bio Inc. (TIL)
TIL trades on Nasdaq in Health Care, Biotechnology: Biological Products (No Diagnostic Substances). Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$6.18
-6.08% on the day
Market cap
$41.9M
Nano cap
Revenue
No annual revenue filed since the period ending 2021-12-31
Net income
No annual revenue filed since the period ending 2021-12-31
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026.
Profile
| Field | Value |
|---|---|
| Ticker | TIL on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) |
| Country | United States |
| IPO year | 2021 |
| SEC CIK | 0001789769 |
| SEC industry code | Biological Products, (No Diagnostic Substances) |
| Incorporated in | NY |
Financials
No annual revenue filed since the period ending 2021-12-31.
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | 424B5 | 2025-03-31 |
| Latest annual report | 10-K | 2026-03-27 |
| Latest quarterly / interim | 10-Q | 2026-08-13 |
| Latest current report | 8-K | 2026-08-13 |
| Latest proxy | DEFA14A | 2026-04-24 |
Source: SEC EDGAR submissions feed, 248 recent filings. All filings on EDGAR.
Peers in Biotechnology: Biological Products (No Diagnostic Substances)
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| BSEM | BioStem Technologies Inc. | $2.25 | -7.79% | $42.0M |
| EXOZ | eXoZymes Inc. | $4.59 | -9.11% | $42.7M |
| INMB | INmune Bio Inc. | $1.68 | -5.62% | $46.6M |
| IMA | ImageneBio Inc. | $4.24 | -0.23% | $48.1M |
| CRBU | Caribou Biosciences Inc. | $0.4700 | -5.41% | $50.4M |
| GNTA | Genenta Science S.p.A. | $0.7220 | -4.99% | $34.8M |
| MGX | Metagenomi Therapeutics Inc. | $0.9173 | -10.07% | $34.7M |
| ALGS | Aligos Therapeutics Inc. | $5.51 | -0.36% | $34.4M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier